The University of Maryland uses the LA-960 to Enhance Studies in Intra-lymph Node Injection
There is a local version available of this page. Change to the local version?
United States

The University of Maryland uses the LA-960 to Enhance Studies in Intra-lymph Node Injection

Back to Particle Characterization Products Overview
Back to Particle Webinar List

Webinar Description

Joshua Gammon, from the University of Maryland, will present how locally controlled release vaccines demonstrate an enhanced immune response in mice and how this platform may be applied to therapeutic cancer vaccinations. Data demonstrating the intra-lymph node depot platform can be harnessed to inhibit immune mediated destruction of host tissues as a therapeutic treatment for autoimmune diseases will also be presented. If you're in the pharmaceutical industry, you'll want to hear more about this ground breaking research.

Informationsanfrage

Sie haben Fragen oder Wünsche? Nutzen Sie dieses Formular, um mit unseren Spezialisten in Kontakt zu treten.

* Diese Felder sind Pflichtfelder.

Corporate